维拉帕米或安慰剂治疗的心肌梗死后患者血清脂蛋白的变化
Variation of serum lipoproteins in postmyocardial infarction patients treated with verapamil or placebo.
作者信息
Strunge P, Engby B, Schmidt E, Trostmann A F
出版信息
Acta Med Scand Suppl. 1984;681:53-7. doi: 10.1111/j.0954-6820.1984.tb08678.x.
Abstract
The effect of verapamil on plasma lipids and lipoproteins was studied in 64 patients taking part in a double blind controlled trial of verapamil versus placebo in post myocardial infarction. During a six month treatment period no significant difference was seen in plasma cholesterol, triglycerides, high density lipoproteins or low density lipoproteins.
摘要
在一项维拉帕米与安慰剂治疗心肌梗死后患者的双盲对照试验中，对64名患者研究了维拉帕米对血脂和脂蛋白的影响。在六个月的治疗期间，血浆胆固醇、甘油三酯、高密度脂蛋白或低密度脂蛋白均未观察到显著差异。
Zotero 插件